CCL22 and hepatocellular carcinoma: In hepatocellular carcinoma (HCC), increased TGF-β signaling, which is associated with persistent hepatitis B virus (HBV) infection, results in suppression of miR-34a and subsequently enhances the production of the chemokine CCL22, which promotes the recruitment of regulatory T cells [127].